- Nano Express
- Open Access
Facile Synthesis of Amine-Functionalized Eu3+-Doped La(OH)3 Nanophosphors for Bioimaging
Nanoscale Res Lettvolume 6, Article number: 24 (2010)
Here, we report a straightforward synthesis process to produce colloidal Eu3+-activated nanophosphors (NPs) for use as bioimaging probes. In this procedure, poly(ethylene glycol) serves as a high-boiling point solvent allowing for nanoscale particle formation as well as a convenient medium for solvent exchange and subsequent surface modification. The La(OH)3:Eu3+ NPs produced by this process were ~3.5 nm in diameter as determined by transmission electron microscopy. The NP surface was coated with aminopropyltriethoxysilane to provide chemical functionality for attachment of biological ligands, improve chemical stability and prevent surface quenching of luminescent centers. Photoluminescence spectroscopy of the NPs displayed emission peaks at 597 and 615 nm (λex = 280 nm). The red emission, due to 5D0 → 7F1 and 5D0 → 7F2 transitions, was linear with concentration as observed by imaging with a conventional bioimaging system. To demonstrate the feasibility of these NPs to serve as optical probes in biological applications, an in vitro experiment was performed with HeLa cells. NP emission was observed in the cells by fluorescence microscopy. In addition, the NPs displayed no cytotoxicity over the course of a 48-h MTT cell viability assay. These results suggest that La(OH)3:Eu3+ NPs possess the potential to serve as a luminescent bioimaging probe.
Lanthanide-doped phosphors have been investigated and employed in a broad range of technological applications such as solar energy converters, fluorescent lighting and high-performance displays [1, 2]. Recently, nanophosphors (NPs) have received significant attention for use in biological sensing [3–5] and imaging applications [6, 7] due to their unique physical and optical properties. As fluorescent probes, similar to semiconductor quantum dots (QDs), these luminescent NPs offer several advantages over conventional organic fluorophores, including high photochemical stability, large Stokes shift and tunable fluorescence emission . In addition, these rare-earth-based nanoparticles exhibit several distinct and useful characteristics for monitoring molecular and biological interactions [8, 9]. Newly developed NPs exhibit long fluorescence lifetimes, no photoblinking and lower cytotoxicity, which make them attractive alternatives to QDs.
The unique photophysical properties of trivalent lanthanide (Ln3+) ions, which act as luminescence activators in these NPs, result from electronic transitions within the 4f shell. Electrons in these 4f orbitals are shielded from interaction with the chemical environment by the 5s and 5p shells, which are lower in energy, but spacially located outside of the 4f orbitals . This unique electronic configuration gives rise to emission spectra that are characterized by sharp peaks, whose spectral positions are independent of their matrix. However, host materials play a critical role influencing the fine structure and emission intensities by absorbing excitation light and transferring energy to the Ln3+ ions. In addition, this matrix can reduce non-radiative relaxation, such as the O–H vibration of water, which results in luminescence quenching [11, 12]. Lanthanide chelates that bind Ln3+ ions and incorporate organic chromophores, which serve as antenna or sensitizers, have been developed as bioprobes for time-resolved luminescent (TRL) immunoassays and Forster resonant energy transfer (FRET) experiments [13–15]. Although versatile, these organic complexes are subject to photochemical degradation, which remains a major challenge in the development of these biological probes.
In response to a growing demand for more sensitive and robust fluorescence bioimaging agents, inorganic Ln3+-doped NPs composed of rare-earth oxides, oxysulfides, phosphates and fluorides are currently being actively investigated [8, 9]. In these NP platforms, the host matrices tightly bind and sensitize a variety of Ln3+ ions allowing for a wide range of emission colors through selection of dopants. One of the most widely used phosphor activators is trivalent europium (Eu3+) due to its well-characterized emission spectrum resulting from 5DJ(J = 0,1,2) → 7FJ(J = 0,1,2,3) transitions. The use of stable Eu2O3 is limited by high cost and poor luminescence due to strong concentration quenching . In order to improve Eu3+ emission, various rare-earth host NPs have been synthesized by modification of conventional phosphor fabrication processes, such as solid-state and pyrolysis reactions [17, 18]. Although efficient in producing highly luminescent NPs, these synthesis methods typically require specialized equipment and can suffer from particle aggregation limiting their use under physiological conditions. Recent efforts to produce NPs for biological applications have focused on colloidal synthesis methods capable of producing dispersed water-soluble NPs. In addition, surface modification of NPs to improve biocompatibility and allow for conjugation of biological ligands continues to be actively investigated [19–21].
In this study, we present a facile synthesis process to produce ultrafine Eu3+-doped NPs for use as luminescent bioimaging probes. Here, lanthanum hydroxide is utilized as a rare-earth matrix material due to its lack of inherent luminescence  and straightforward conversion to oxides or oxysulfides through dehydration or sulfuration . This wet chemical strategy employs a low-molecular weight poly(ethylene glycol) (PEG) as a high-boiling point solvent allowing for monodispersed NP formation and in situ polymer coating. The physically adsorbed amphililic PEG serves as a temporary barrier to particle aggregation and allows for convenient solvent exchange for subsequent surface modification in either aqueous or organic solutions. Here, we demonstrate surface coating with aminopropyltriethoxysilane (APTES) to improve chemical stability and provide amine functional groups for conjugation of biomolecules. As-synthesized and APTES-coated NPs were characterized to determine their physiochemical and photoluminescence properties. Functionalized NPs were also evaluated as luminescent probes in a conventional biological imaging system and in vitro fluorescence microscopy. In addition, an initial assessment of the biocompatibility of these NPs was performed using a MTT cell viability assay.
Lanthanum nitrate hexahydrate (La(NO3)3·6H2O), poly(ethylene glycol) (PEG, MW 570-630), titianum (IV) isopropoxide Ti(OPr)4 (3-aminopropyl)trimethoxysilane (APTES), dimethyl sulfoxide (DMSO) and MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) were purchased from Sigma–Aldrich (St. Louis, MO). Europium oxide (Eu2O3), nitric acid (HNO3) and toluene were purchased from Acros Organics (Morris Plains, NJ). Sodium hydroxide (NaOH) and 200 proof ethanol (EtOH) were purchased from Fisher Chemical (Fairlawn, NJ). All reagents were used without further purification. Deionized (D.I.) water was obtained from an ultrapure water purification system (Barnstead Nanopure, Thermo Scientific, Dubuque, IA). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), phosphate-buffered saline (PBS), penicillin/streptomycin, TrypLE and Trypan blue were purchased from Gibco (Invitrogen, Carlsbad, CA).
Nanophosphor Synthesis and Surface Modification
Eu3+-doped NPs were obtained through a high-temperature precipitation in low-molecular weight PEG. Initially, 39 mg Eu2O3 was dissolved in 0.2 ml 35% HNO3 under magnetic stirring. Then, 1.9 g La(NO3)3·6H2O was dissolved in 0.8 mL of D.I. water and combined with the dissolved Eu2O3 and 40 mL of PEG. A volume of 1.0 mL of 6 M NaOH was then added dropwise under vigorous stirring, and the mixture was heated to 140°C for 1 h. The reaction vessel was then sealed and heated for 3 h at 140°C. The resulting colloidal solution was cooled to room temperature and diluted 1:10 in EtOH. To isolate the NPs, 50-mL aliquots of the NPs mixture were centrifuged at ~2,500 RPM for 5 min. The supernatant was decanted to remove excess PEG and reaction byproducts. NPs were washed twice by redispersing them in 50 mL of EtOH followed again by centrifugation and decanting the supernatant. The particles were then resuspended in 50 mL of anhydrous toluene. Surface modification was performed with the addition of 0.5 mL APTES and 50 μL Ti(OPr)4, as a catalyst, for 12 h at 40°C in an ultrasonic bath (Branson Ultrasonic Corp., Danbury, CA). The coated NPs were centrifuged, and excess APTES and Ti(OPr)4 were decanted. The resulting NPs were purified by washing three times with ethanol and D.I. water, respectively.
Physiochemical Characterization of Nanophosphors
Transmission electron microscopy (TEM) samples were prepared by dipping 400-mesh copper grids (Veco, Ted Pella, Redding, CA) in a diluted suspension of NPs in EtOH. The grids were then dried and imaged on a JEOL TEM1230 (Tokyo, Japan) operating at 80 kV. Digital TEM images were acquired with a Gatan 967 (Pleasanton, CA) slow scan, cooled CCD camera. Particle size distribution was calculated using NIH ImageJ with the particle size analyzer (PSA) macro. Powder X-ray diffraction (XRD) patterns were acquired from dried samples with a PANalytical X'Pert (Almelo, Netherlands) diffractometer using Cu-Kα radiation (λ = 1.541Å) at 40 kV and 20 mA. X-ray photoelectron spectroscopy (XPS) experiments were carried out using a Surface Science Instrument S-probe spectrophotometer (Newburyport, MA) with a monochromatized Al X-ray source and 5 eV flood gun for charge neutralization. X-ray spot size for the acquisition was approximately 800 μm. Pressure in the analytical chamber during spectral acquisition was less than 5 × 10-9 Torr.
Photoluminescence Characterization of Nanophosphors
Photoluminescence characterization was performed on a FluoroMax-4 spectrofluorometer (Horiba Scientific, Edison, NJ). Images of NP emission intensity as a function of concentration were obtained on a Xenogen Illumina system (Caliper Life Sciences, Hopkinton, MA). For imaging, optical phantoms were prepared over a range of concentration in 1% agarose. Fluorescence emission was normalized to photons per second per centimeter squared per steradian (p/s/cm2/sr).
In Vitro Imaging Assay
Human cervical adenocarcinoma HeLa cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C in a humidified atmosphere with 5% CO2. Cells were grown on 75-cm2 cell-culture flasks with 10 mL of media that was changed every second day. To assess the optical detection of the NPs in a biological sample, cells were incubated with the NPs at a concentration of 100 μg NP/ml for 4 h at 37°C. Cells were then washed twice with PBS and incubated with TrypLE solution (substitute for porcine trypsin) for 5 min at 37°C to detach them from the flask. Cell density was determined through staining with trypan blue and counting cells using a hemocytometer with 0.9-mm3 counting chamber. To evaluate NP fluorescence from bulk cell sample, 106 cells were fixed in methanol at -20°C for 15 min and centrifuged to isolate a pellet for imaging. For fluorescence microscopy, cells preincubated with NPs, as described earlier, were seeded on 24-mm glass cover slips and incubated for 18 h to allow them to attach. Cells were then washed with PBS three times and fixed in methanol at -20°C for 15 min. The cover slips were then mounted on slides using Prolong Gold antifade solution with DAPI (4',6-diamidino-2-phenylindole) (Invitrogen, Carlsbad, CA) for cell nuclei staining and fluorescence preservation. The slides were examined by fluorescence microscopy using a Leica fluorescence microscope (Wetzlar, Germany) equipped with excitation/emission filter cubes for DAPI and FITC (fluorescein isothiocyanate). Here, an FITC 515-nm-long-pass emission filter was used to acquire all NP emission in the green and red spectral region. By convention, signal collected by the DAPI and FITC filter cubes were colored blue and green, respectively.
Cytotoxicity (MTT) Assay
Human breast adenocarcinoma MCF7 cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C in a humidified atmosphere with 5% CO2. Cells were then cleaved with TrypLE and counted using a hemocytometer, as described earlier. The cells were then seeded on 96-well plates (5,000 cells/well) in DMEM w/o phenol red. After 12-h incubation, cells were incubated with APTES-coated NPs at concentrations of 0, 0.1, 1.0, 10 and 100 μg/mL in 200 μL DMEM w/o phenol red. In addition, control (cells only) and blank (no cells) samples were also present on the well plates. The cells were then incubated at 37°C for 12, 24 and 48 h. Four hours before the end of each time point, 20 μL of 12 mM MTT was added to each well. Upon completion of the incubation, all but 25 μL of the medium was removed, and 50 μL of DMSO was added to each well to dissolve the formazan crystals. The samples were then mixed thoroughly with pipetting, and the absorbance read at 540 nm on a microplate reader (Tecan, Mannedorf, Switzerland).
Results and Discussion
Nanophosphor Synthesis and Surface Modification
The overall NP synthesis and functionalization process is illustrated in Figure 1. This straightforward procedure can be carried out with general chemistry laboratory equipment and utilizes relatively low-cost reagents. In this study, the size and morphology of the NPs produced by this process were analyzed by TEM. As shown in Figure 2a, NPs are roughly spherical in shape with a mean diameter of ~3.5 nm. Measurement of particle size with the NIH ImageJ image software package displayed good uniformity and narrow size distribution (Figure 2b) of the NPs, which are significant advantages of the synthesis procedure. The size of these NPs is on the order of biomacromolecules, such as cell-surface receptors or antigens, making them ideal for molecular imaging applications. In this size range, the NPs can also be taken up by cells via endocytotic vesicles, which are typically 40–60 nm in diameter . Furthermore, the small size of these NPs opens the potential for in vivo applications by overcoming the size restriction of biological barriers [24, 25] and allowing for clearance to minimize long-term toxicity [26, 27].
The structure and composition of the NPs were analyzed by X-ray characterization techniques. Powder XRD was performed on the APTES-coated NPs (Figure 2c). Peaks consistent with crystalline La(OH)3 were observed (JCPDS 36-1481); however, additional peaks were also detected and attributed to the presence of La2O3 and possibly the Eu3+ dopant. Furthermore, the relatively low intensity of the peaks suggests a significant amorphous phase is present and likely due to extensive reconstruction at the surface of these nanoparticles. In comparison with previous reports [28, 29], the use of PEG as a surfactant in this hydrothermal synthesis of La(OH)3 NPs significantly reduces the overall size of the nanostructure with a trade-off of well-defined crystal structure. Previously, polyol synthesis methods employing diethylene glycol to produce Y2O3:Eu3+ and Gd2O3:Eu3+ NPs have been reported . Here, we employ PEG as a more biologically friendly and solvent compatible reaction medium for surface modification. Further processing by annealing the NPs synthesized in PEG and conversion to lanthanum oxide or lanthanum oxysulfide  are potential areas of optimization for this NP platform; however, these processes are beyond the scope of this work.
To confirm the NP composition and evaluate the surface modification process, both as-synthesized and APTES-coated NPs were characterized by XPS. The survey scan obtained from the as-synthesized NPs (Figure 3a) confirms the primary composition of lanthanum and oxygen with main peaks of La 3d5 and O 1s centered at ca. 835.2 and 531.1 eV, respectively. In addition, the presence of physically adsorbed PEG in these samples likely contributes to the prominent C 1 s peak. The low concentration of the Eu3+ dopant (<5 mol%) is below the detection limit of this technique. Confirmation of the dopant in NPs is described in the following section. The XPS survey scan of the APTES-coated NPs (Figure 3b) displays peaks characteristic of the amine-bearing silane in addition to the NP matrix. Main peaks of Si 2 s and N 1s at binding energies of 152.2 and 400.7 eV, respectively, confirm the surface functionalization of NPs. An additional peak at 458.3 eV was identified as titanium (Ti 2p3), which was also incorporated in the coating from the Ti(OPr)4 catalyst . The presence of this siloxane bound coating improves the chemical stability and protects the Eu3+ luminescent centers that may be located at or near the surface of the NP from quenching by water. Furthermore, the terminal amine group serves as a convenient linking chemistry for bioconjugation [33, 34], which is necessary for biological applications.
The optical properties of the La(OH)3:Eu3+ NPs were evaluated by fluorescence spectroscopy under UV excitation in the broad Eu–O charge transfer band [35, 36]. The photoluminescence spectra of the as-synthesized NPs, shown in Figure 4a (λex = 280 nm), display typical Eu3+ emission peaks at 597 and 615 nm due to the 5D0 → 7F1 (magnetic-dipole) and 5D0 → 7F2 (electronic-dipole) transitions, respectively. The emission spectra of APTES-coated NPs, shown in Figure 4b, display the same peak positions; however, the intensity of the 615-nm emission relative to the 5D0 → 7F1 is increased. The stronger 5D0 → 7F2 transition is likely due to the migration of Eu3+ ions to crystalline positions in the NP lattice during aging over the surface modification process. In addition, the intensity of emission in the red spectral region was enhanced by surface coating, as described previously. Analysis of the APTES-coated NP in an optical phantom (Figure 4b inset, 5 mg/mL) displayed ~44% enhancement in emission intensity when compared to bare NPs (Figure 4a inset).
In biological imaging applications where UV radiation can damage organic structures, blue excitation has been employed with Eu3+ complexes . To demonstrate the use of these NPs in a conventional bioimaging system, optical phantoms containing various concentrations of APTES-coated NPs (0, 0.01, 0.05, 0.1, 0.5, 1.0 mg/mL) were analyzed in an IVIS Illumina fluorescence imaging system (λex = 430 nm). The fluorescence intensity, expressed in radiance, was measured and plotted as a function of concentration (Figure 5). The NPs displayed a linear relationship of luminescence with concentration potentially enabling their use in biological sensing and imaging applications.
In Vitro Cell Labeling
Fluorescence labeling and optical detection of molecular interactions has become an indispensable tool in biology. To demonstrate the efficacy of the amine-functionalized La(OH)3:Eu3+ NPs to serve as a luminescent probe under biological conditions, an in vitro imaging experiment was performed with human cervical cancer HeLa cells. In this assay, cells were labeled with APTES-coated NPs via charge interaction between the positive amine terminal groups and negatively charged cell membrane. In addition, non-specific uptake of NPs was likely due to the high incubation concentration (100 μg/mL) and extended incubation times (4 h). After the NP incubation, the cells were washed, cleaved, and centrifuged. The resulting cell pellet containing ~ 106 cells and a control sample w/o NPs were imaged with the IVIS Illumina imaging system (Figure 6). The successful fluorescent labeling of the cells with NPs was observed by the red emission in comparison with control cells.
To visualize the luminescence of these NPs on the cellular level, La(OH)3:Eu3+ NP labeled HeLa cells were seeded on microscope cover slips and imaged with a fluorescence microscope (Figure 7a–d). In this in vitro fluorescence microscopy experiment, HeLa cells were stained with DAPI to identify the cell nucleus (Figure 7b, blue), while the NPs were visualized with a FITC excitation (420–490 nm)/emission (515 nm long pass) filter set (Figure 7c, green). The emission of the probes localization in the cell cytoplasm, likely within the endosomal or lysosomal compartments, demonstrates their ability to serve as optical imaging bioprobes. In addition, after incubation with the NPs, no changes in cell morphology or other visual signs of cytotoxicity were observed in the phase contrast images (Figure 7a).
To further investigate the biocompatibility of the APTES-coated La(OH)3:Eu3+ NPs, these NPs were evaluated with human breast adenocarcinoma MCF7 cells as a model cell line. The cells were grown for intervals of 12, 24 and 48 h with a NP concentration range typically used in biological assays (0, 0.1, 1.0, 10 and 100 μg/mL). Cell proliferation was monitored with a MTT assay in which the reduction of a yellow tetrazolium salt in metabolically active cells forms purple formazan crystals . The spectroscopic quantification of the formazan corresponds with cellular viability shown in Figure 8a–c. In this assay, no significant cytotoxicity was observed over the concentration entire range tested during the 48 h of the experiment. These results suggest that amine-functionalized La(OH)3:Eu3+ NPs may potentially serve as optical contrast agents for bioimaging.
In this study, we have developed a facile synthesis process to produce luminescent water-soluble La(OH)3:Eu3+ NPs for biological applications. The NPs obtained from this process are ~ 3.5 nm in size and display optical emission typical for Eu3+-activated probes with 5D0 → 7F1 and 5D0 → 7F2 transitions. Surface functionalization with APTES was confirmed with XPS and shown to enhance luminescence intensity by ~ 44%. In addition, the amine terminal groups of the APTES-coated NPs provide reactive sites for bioconjugation. Combining the ability to attach a variety of biological ligands with selection of Ln3+ dopant–tuned emission, these La(OH)3 NPs may serve as effective multiplex imaging agents for various biological assays . To demonstrate the luminescence of the NPs under biological conditions, an in vitro experiment was performed with HeLa cells. NP emission was observed in the cells by both a conventional bioimaging system and through fluorescence microscopy. In addition, the NPs displayed no apparent cytotoxicity over the course of a 48-h MTT cell viability assay making them suitable optical probes for bioimaging applications.
Justel T, Nikol H, Ronda C: Angew Chem Int Ed. 1998, 37: 22. 10.1002/(SICI)1521-3773(19981204)37:22<3084::AID-ANIE3084>3.0.CO;2-W
Feldmann C, stel TJ, Ronda CR, Schmidt PJ: Adv Func Mater. 2003, 13: 7.
Casanova D, Bouzigues C, Nguyen TL, Ramodiharilafy RO, Bouzhir-Sima L, Gacoin T, Boilot JP, Tharaux PL, Alexandrou A: Nat Nanotechnol. 2009, 4: 9. 10.1038/nnano.2009.200
Dosev D, Nichkova M, Liu M, Guo B, Liu GY, Hammock BD, Kennedy IM: J Biomed Opt. 2005, 10: 6. 10.1117/1.2136347
Nichkova M, Dosev D, Perron R, Gee SJ, Hammock BD, Kennedy IM: Anal Bioanal Chem. 2006, 384: 3. 10.1007/s00216-005-0246-8
Wu S, Han G, Milliron DJ, Aloni S, Altoe V, Talapin DV, Cohen BE, Schuck PJ: Proc Natl Acad Sci USA. 2009, 106: 27. 10.1073/pnas.0900125106
Chatterjee DK, Rufaihah AJ, Zhang Y: Biomaterials. 2008, 29: 7. 10.1016/j.biomaterials.2007.10.051
Shen J, Sun LD, Yan CH: Dalton Trans. 2008., 42:
Wang F, Tan WB, Zhang Y, Fan X, Wang M: Nanotechnology. 2006, 17: 1. 10.1088/0957-4484/17/1/R01
Werts MH: Sci Prog. 2005.,88(2): 10.3184/003685005783238435
Parker D, Williams JAG: J Chem Soc-Dalton Trans. 1996., 18:
Bunzli JC: Chem Rev. 2010, 110: 5. 10.1021/cr900362e
Bunzli JC, Piguet C: Chem Soc Rev. 2005, 34: 12. 10.1039/b406082m
Eliseeva SV, Bunzli JC: Chem Soc Rev. 39: 1.
Thibon A, Pierre VC: Anal Bioanal Chem. 2009, 394: 1. 10.1007/s00216-009-2683-2
Dexter DL, Schulman JH: J Chem Phys. 1954, 22: 6. 10.1063/1.1739858
Dosev D, Nichkova M, Dumas RK, Gee SJ, Hammock BD, Liu K, Kennedy IM: Nanotechnology. 2007, 18: 5. 10.1088/0957-4484/18/5/055102
Kubrin R, Tricoli A, Camenzind A, Pratsinis SE, Bauhofer W: Nanotechnology. 2010, 21: 22. 10.1088/0957-4484/21/22/225603
Sivakumar S, Diamente PR, van Veggel FC: Chemistry. 2006, 12: 22.
Diamente PR, Burke RD, van Veggel FC: Langmuir. 2006, 22: 4. 10.1021/la052589r
Wang F, Zhang Y, Fan XP, Wang MQ: Nanotechnology. 2006, 17: 5.
Jiang Y, Wu Y, Xie Y, Qian Y-T: J Am Ceram Soc. 2000, 83: 10.
Debbage P, Jaschke W: Histochem Cell Biol. 2008, 130: 5. 10.1007/s00418-008-0511-y
McNeil SE: J Leukoc Biol. 2005, 78: 3. 10.1189/jlb.0205074
Sun C, Lee JS, Zhang M: Adv Drug Deliv Rev. 2008, 60: 11. 10.1016/j.addr.2008.03.018
Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV: Nat Biotechnol. 2007, 25: 10.
Choi HS, Liu W, Liu F, Nasr K, Misra P, Bawendi MG, Frangioni JV: Nat Nanotechnol. 2010, 5: 1. 10.1038/nnano.2009.314
Mu Q, Chen T, Wang Y: Nanotechnology. 2009, 20: 34.
Tang B, et al.: Nanotechnology. 2004, 15: 12.
Bazzi R, Flores MA, Louis C, Lebbou K, Zhang W, Dujardin C, Roux S, Mercier B, Ledoux G, Bernstein E, Perriat P, Tillement O: J Colloid Interface Sci. 2004, 273: 1. 10.1016/j.jcis.2003.10.031
Liu Z, Sun X, Xu S, Lian J, Li X, Xiu Z, Li Q, Huo D, Li J-G: J Phys Chem C. 2008, 112: 7.
Arkles B: Silane coupling agents: connecting across boundaries V2.0. 2006.
Hermanson G: Bioconjugate techniques. Academic Press, San Diego; 1996.
Aslam M, Dent A: Bioconjugation. Macmillan Reference Ltd, London; 1998.
Park JK, Park SM, Kim CH, Park HD, Choi SY: J Mater Sci Lett. 2001, 20: 24.
Hosono E, Fujihara S: Chem Commun. 2004., 18:
Werts MHV, Duin MA, Hofstraat JW, Verhoeven JW: Chem Commun. 1999., 9:
Mosmann T: J Immunol Methods. 1983, 65: 1–2. 10.1016/0022-1759(83)90303-4
Ehlert O, Thomann R, Darbandi M, Nann T: ACS Nano. 2008, 2: 1. 10.1021/nn7002458
We gratefully acknowledge our funding sources from the National Science Foundation (Grant No. 0854492) and the NIH (Grant No. R01 CA133474) and NCI ICMIC (Grant No. P50 CA114747). We also acknowledge the laboratory facilities and equipment support provided by the Canary Foundation and Dr. Martin Brown. In addition, we thank Dr. Shoucheng Ning for donating tumor cell lines used in this study.